Trial intelligence / Profile preview

Tranexamic acid for post-operative pain after shoulder arthroscopy

2021-005710-34Phase 3Active

Sponsor
Clinique Jean Villar
Start
Jan 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postoperative pain comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Opioid use in first 24 hours. Started Jan 2022; status: active.

02

Drugs

tranexamic acid
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2021-005710-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-005710-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call